Treace Medical Concepts (TMCI) Gross Margin (2020 - 2025)
Historic Gross Margin for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to 79.07%.
- Treace Medical Concepts' Gross Margin fell 10700.0% to 79.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 79.87%, marking a year-over-year decrease of 7400.0%. This contributed to the annual value of 80.37% for FY2024, which is 8300.0% down from last year.
- As of Q3 2025, Treace Medical Concepts' Gross Margin stood at 79.07%, which was down 10700.0% from 79.67% recorded in Q2 2025.
- Treace Medical Concepts' Gross Margin's 5-year high stood at 83.94% during Q4 2021, with a 5-year trough of 79.07% in Q3 2025.
- Its 5-year average for Gross Margin is 81.05%, with a median of 80.9% in 2021.
- As far as peak fluctuations go, Treace Medical Concepts' Gross Margin skyrocketed by 78500bps in 2021, and later crashed by -20700bps in 2022.
- Treace Medical Concepts' Gross Margin (Quarter) stood at 83.94% in 2021, then fell by -2bps to 81.87% in 2022, then dropped by 0bps to 81.56% in 2023, then dropped by -1bps to 80.74% in 2024, then dropped by -2bps to 79.07% in 2025.
- Its Gross Margin was 79.07% in Q3 2025, compared to 79.67% in Q2 2025 and 79.69% in Q1 2025.